| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wilson Daniel G. | Chief Financial Officer | C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO | /s/ Marc Rosenbaum, attorney-in-fact | 03 Sep 2025 | 0001860745 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRTC | Common Stock | Sale | $123,285 | -737 | -1.8% | $167.28 | 39,470 | 02 Sep 2025 | Direct | F1 |
| holding | IRTC | Common Stock | 100 | 02 Sep 2025 | Held through a Family Trust | F2 |
| Id | Content |
|---|---|
| F1 | These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs. |
| F2 | These shares represent an indirect ownership through The Wilson Living Trust dated July 9, 2015, of which Mr. Wilson is the Trustee. |